Richardson DL, Quintanilha JCF, Danziger N, Li G, et al. Correction: Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice. Clin Cancer Res 2025;31:3599.
PMID: 40808406